Literature DB >> 9372220

Pre- and postsynaptic modulation of spinal GABAergic neurotransmission by the neurosteroid, 5 beta-pregnan-3 alpha-ol-20-one.

C A Reith1, K T Sillar.   

Abstract

The neuroactive steroid 5 beta-pregnan-3 alpha-ol-20-one (5 beta 3 alpha) modulates GABAA receptor function by potentiating postsynaptic GABA currents. While much is now known about the postsynaptic action of neurosteroids, far less is known about how they affect neurotransmission. We have investigated the synaptic actions of 5 beta 3 alpha in a simple vertebrate model, the embryo of the clawed toad, Xenopus laevis, in which a known GABAergic pathway, activated by the rostral cement gland, terminates swimming when the animal contacts an obstruction. Cement gland stimulation evokes bicuculline-sensitive inhibitory postsynaptic potentials (IPSPs) in motorneurones that terminate swimming and which are greatly enhanced by the presence of (1-5 microM) 5 beta 3 alpha. In the presence of TTX, depolarising inhibitory potentials are recorded with KCl-filled microelectrodes reflecting the spontaneous release of transmitter. The majority are glycinergic with durations of 20-80 ms and are blocked by strychnine while the remainder are GABAergic with durations of 90-200 ms and are abolished by bicuculline. We show here that, in the presence of 5 beta 3 alpha, the spontaneous GABA IPSPs lengthen dramatically in some cases to over 500 ms, but the glycine potentials are unaffected. The steroid has no other detectable postsynaptic effects in that the range of amplitudes of GABA potentials is unaffected and there is no change in the resting membrane potential. However, 5 beta 3 alpha also caused a marked increase in the rate of occurrence of spontaneous GABA potentials. This suggests a novel presynaptic site of action in which the steroid enhances the probability of vesicular GABA release from GABA terminals.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9372220     DOI: 10.1016/s0006-8993(97)00809-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  Neurosteroid modulation of GABA IPSCs is phosphorylation dependent.

Authors:  A Fáncsik; D M Linn; J G Tasker
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

Review 2.  Fast nongenomic effects of steroids on synaptic transmission and role of endogenous neurosteroids in spinal pain pathways.

Authors:  Rémy Schlichter; Anne Florence Keller; Mathias De Roo; Jean-Didier Breton; Perrine Inquimbert; Pierrick Poisbeau
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

3.  Brainstem control of activity and responsiveness in resting frog tadpoles: tonic inhibition.

Authors:  T D Lambert; W-C Li; S R Soffe; A Roberts
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2004-02-27       Impact factor: 1.836

4.  Effects of a naturally occurring neurosteroid on GABAA IPSCs during development in rat hippocampal or cerebellar slices.

Authors:  E J Cooper; G A Johnston; F A Edwards
Journal:  J Physiol       Date:  1999-12-01       Impact factor: 5.182

5.  Nitric oxide selectively tunes inhibitory synapses to modulate vertebrate locomotion.

Authors:  David L McLean; Keith T Sillar
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

6.  Diminished neurosteroid sensitivity of synaptic inhibition and altered location of the alpha4 subunit of GABA(A) receptors in an animal model of epilepsy.

Authors:  Chengsan Sun; Zakaria Mtchedlishvili; Alev Erisir; Jaideep Kapur
Journal:  J Neurosci       Date:  2007-11-14       Impact factor: 6.167

7.  Neurosteroid influences on sensitivity to ethanol.

Authors:  Christa M Helms; David J Rossi; Kathleen A Grant
Journal:  Front Endocrinol (Lausanne)       Date:  2012-01-31       Impact factor: 5.555

8.  A behaviorally related developmental switch in nitrergic modulation of locomotor rhythmogenesis in larval Xenopus tadpoles.

Authors:  Stephen P Currie; Denis Combes; Nicholas W Scott; John Simmers; Keith T Sillar
Journal:  J Neurophysiol       Date:  2016-01-13       Impact factor: 2.714

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.